OTC market in Poland 2010. Switch strategies and development forecasts for 2010-2012.

Date: December 22, 2010
Pages: 208
Price:
US$ 2,415.00
Publisher: PMR
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OC67E4C6F37EN
Leaflet:

Download PDF Leaflet

OTC market in Poland 2010. Switch strategies and development forecasts for 2010-2012.
ENGLISH OR POLISH
Single user licence: - US$ 2,415.00
5-user licence: - US$ 3,620.00
Corporate licence: - US$ 4,830.00
Global licence: - US$ 6,040.00

ENGLISH AND POLISH
Single user licence: - US$ 3,380.00
5-user licence: - US$ 5,070.00
Corporate licence: - US$ 6,760.00
Global licence: - US$ 8,450.00


Report description:

The report is a comprehensive analysis of the OTC market in Poland, with a closer look at drugs, dietary supplements and dermocosmetics. The historical data and development forecasts for the individual segments, prepared by PMR’s team of market analysis and economists, were augmented with a presentation of factors affecting the OTC market, such consumer behaviour and legislative environment. The report also provides profiles of the top manufacturers on the Polish OTC market. The publication also contains a section with an analysis of the switch strategy, which looks at examples of recent Rx-to-OTC switches as well as development forecasts for the segment.

What will you find out in this report?
  • Key market events and trends
  • Key characteristics of the Polish OTC market: drugs, dietary supplements, dermocosmetics, including development forecasts for 2010-2012
  • Profiles of the key manufacturers of drugs, dietary supplements and dermocosmetics
  • Analysis of the distribution segment, also including profiles of the largest wholesalers active on the pharmacy and non-pharmacy market and pharmacy chains
  • Analysis of non-pharmacy and online distribution of OTC drugs
  • Information on advertising outlays of OTC producers by media types; largest advertisers and most often advertised OTC products in Poland
  • Information on consumer behaviour affecting the use of OTC products
  • Legal environment of the OTC market in Poland
  • Rx-to-OTC switch: examples of switches and development forecasts
REPORT METHODOLOGY

EXECUTIVE SUMMARY

OVERVIEW OF THE OTC MARKET IN POLAND 2006-2012

Main trends and events on OTC market
  Main trends and events in 2009-2010
  Expected trends and events in 2010-2012
Value of the OTC market in 2008-2012
  OTC market value by distribution channel in 2009
  Value of pharmacy OTC market in 2006-2012
    The main therapeutic categories in the pharmacy market in 2007-2009
  Value of non-pharmacy OTC market in 2007-2012
    The main therapeutic categories in the non-pharmacy market in 2009
  The structure of sales on the non-pharmacy market in 2009-2010
  Value of OTC drugs market in 2007-2012
  Value of dietary supplements market in 2006-2012
  Value of the dermocosmetics market in 2008-2012
    The main categories on the dermocosmetics market
Prices of OTC products
Best-selling OTC products

PROFILES OF THE SELECTED LARGEST MANUFACTURERS OPERATING IN THE OTC MARKET

RX-TO-OTC AND OTC-TO-DIETARY SUPPLEMENT SWITCH STRATEGIES

Overview of the situation in Poland
Rx-to-OTC and OTC-to-dietary supplement switch – marketing strategy in the product development process
  Switch in individual markets as an element of the company global strategy
  Increased share of OTC products in the Polish market
Switch-related benefits and inconveniences
  Benefits
  Inconveniences
  Comparison of benefits of various types of switch
Examples of changes in availability categories of medicinal products on the Polish market
  Weight-loss medicines
  Medicines for allergies
  Smoking-cessation medicines
  Analgesics
  Medicines for diseases of skin and skin appendages
  Asthma/cough medicines and medicines for respiratory system diseases
  Medicines for indigestion/alimentary system diseases
  Medicines for hypertension and circulatory system diseases
  Anti-flu and immune-boosting medicines
  Medicines for bone and teeth diseases
  Vitamin preparations/supplements/hypnotics
Predictions regarding trends concerning the status change in Poland
  Providing for switch in the companies’ marketing strategies
  The most prospective segments
Predictions regarding the Polish market, including the international perspective

DISTRIBUTION OF OTC PRODUCTS

Pharmacy distribution
  Wholesale distribution
    Segment profile
    Profiles of selected key players
  Pharmacies
    Segment overview
    Profiles of selected key players
Non-pharmacy distribution
  Wholesalers
    Segment profile
    Selected key players
  General stores
    Segment profile
    Hypermarkets
    Supermarkets
    Discount stores
    Small grocery stores
    Convenience stores
    Shops at petrol stations
    Kiosks
    Cosmetics/drugstores
Online distribution
  Internet pharmacies

ADVERTISING OF OTC PRODUCTS

Overview of the market
  TV advertising
  Radio advertising
  Outdoor advertising
  Online advertising
  Promotions in retailers’ promotional magazines
  Advertising spending by product groups
    Stop-smoking products
    Analgesics and cold and flu remedies
    Dermocosmetics
Ordering the cessation of advertising of medicinal products

LEGAL ENVIRONMENT

The sale of OTC at non-pharmacy outlets and pharmacy points
  Types of non-pharmacy distribution outlets
  Premises standards and staff qualification requirements
  Criteria for approving medicinal products for retail sale
    Pharmacy points
    Herbal medical stores
    General stores and specialist medical supplies stores
Sale of medicinal products by mail order
Labelling of medicinal product packaging
Medicinal product leaflet
Advertising of OTC products
Composition of dietary supplements
Changes regarding dietary supplements under amendment to the act on safety of food and nutrition
Regulations concerning the switch procedure

CONSUMER BEHAVIOURS

Subjective assessment of health condition
Actions taken to improve health
  Physical activity
  Losing weight
The most frequent disorders and illnesses
Caring about appearance
Actions taken in illness
Taking OTC medicines
Factors driving the decision to purchase OTC medicines
Sources of information about health and medicines
Impact of the economic crisis on purchases of OTC medicines
Places where medical items are purchased
Using the internet and online shopping

THE MACROECONOMIC AND DEMOGRAPHIC SITUATION OF POLAND

GDP
Employment
Wages
Inflation
Income and spending of households
Demographics

ABOUT PMR

CONTACT PMR

LIST OF GRAPHS

1. Positions held by respondents in their firms in Poland (number of respondents), 2010
2. Value (PLN m) and y-o-y change in the OTC product market in Poland, 2008-2012
3. Value (PLN m) and y-o-y change in the OTC product pharmacy market in Poland, 2006-2012
4. Value (PLN m) and y-o-y change in the OTC product non-pharmacy market in Poland, 2007-2012
5. Value (PLN m) and y-o-y change in the OTC drugs market in Poland, 2007-2012
6. Value (PLN m) and y-o-y change in the dietary supplement market in Poland, 2005-2012
7. Value (PLN m) and y-o-y change in the dermocosmetics market in Poland, 2008-2012
8. Number of influenza cases (million) in Poland, 1970-January-September 2010
9. Sales of new OTC products and Rx drugs in Poland (PLN m), 2007-2009
10. Sales of new OTC products and Rx drugs in Poland (number of packages, in millions), 2007-2009
11. Sources of growth on the OTC drug market in Poland, 2009
12. The number of medicinal products approved for trading in Poland, 2005-August 2009
13. Herbapol Lublin financial results (PLN m) in Poland, 2008-2010
14. Value (PLN m) and y-o-y change in the OTC product market in Poland, 2008-2012
15. OTC product market in Poland, by main product categories, value share and y-o-y growth, 2009
16. Total sales of OTC products in Poland, by product status, 2009
17. OTC product market in Poland, by sales channel, 2009
18. Pharmacy sales of OTC products in Poland, by product status, 2009
19. Non-pharmacy sales of OTC products in Poland, by product status, 2009
20. Value (PLN m) and y-o-y change in the OTC product pharmacy market in Poland, 2006-2012
21. The main categories of OTC products in Poland (PLN m), pharmacy market, 2007-2009
22. Sales of OTC anti-smoking preparations in Poland (PLN m), 2007-2009
23. Value (PLN m) and y-o-y change in the OTC product non-pharmacy market in Poland, 2007-2012
24. The main therapeutic categories of drugs in non-pharmacy trading in Poland, in terms of value, 2009
25. The structure of sales of painkillers on the non-pharmacy market in Poland, in terms of value, August 2009-July 2010
26. The structure of sales of vitamin preparations and synthetic sweeteners on the non-pharmacy market in Poland, in terms of value, August 2009-July 2010
27. The structure of sales of lozenges on the non-pharmacy market in Poland, in terms of value, August 2009-July 2010
28. The structure of sales of gastric tablets on the non-pharmacy market in Poland, in terms of value, August 2009-July 2010
29. Value (PLN m) and y-o-y change in the OTC drugs market in Poland, 2007-2012
30. OTC drugs market in Poland, by sales channel, 2009
31. Value (PLN m) and y-o-y change in the dietary supplement market in Poland, 2005-2012
32. Value (PLN m) and y-o-y change in the dermocosmetics market in Poland, 2008-2012
33. Dermocosmetics share in the Polish pharmacy market in value terms, September 2008-August 2009
34. The share of sales through pharmacies in sales of body care cosmetics in Poland, in value terms, H1 2010
35. The share of sales through pharmacies in sales of facial care cosmetics for women in Poland, in value terms, H1 2010
36. Average prices of OTC products per package and y-o-y change in Poland (PLN), 2002-January-August 2010
37. Average margins on non-reimbursed products and y-o-y change in Poland, 2005-January-August 2010
38. The structure of the OTC drug price in Poland, including margins, 2010
39. Most popular cold preparation brands in Poland (% of responses), July 2008-June 2009
40. Most popular gastric preparation brands in Poland (% of responses), July 2008-June 2009
41. Market shares of individual brands of dermocosmetics in Poland, in terms of value, 2009
42. Top 20 manufacturers of OTC products in Poland, by value, September 2008-August 2009
43. Top manufacturers of vitamin products and analgesics in Poland, by value, 2009
44. Aflofarm Fabryka Lekow sales revenues and net profit (PLN m), 2005-2009
45. Aflofarm Farmacja Polska sales revenues and net profit (PLN m), 2005-2009
46. Bayer sales revenues and net profit in Poland (PLN m), 2004-2009
47. GlaxoSmithKline Consumer Healthcare sales revenues and net profit/loss in Poland (PLN m), 2001-2009
48. Hasco-Lek sales revenues and net profit (PLN m), 2005-2009
49. L’Oreal sales revenues in Poland (PLN m) and their y-o-y change, 2005-2009
50. Nepentes sales revenues and net profit (PLN m), 2006-H1 2010
51. Polpharma sales revenues and net profit (PLN m), 2006-Q1 2010
52. Sanofi-Aventis sales revenues and net profit in Poland (PLN m), 2004-2008
53. Zentiva sales revenues and net profit in Poland (PLN m), 2005-2009
54. Teva Pharmaceuticals sales revenues and net profit/loss in Poland (PLN m), 2006-2008
55. Teva Kutno sales revenues and net profit/loss (PLN m), 2004-2008
56. Pliva Krakow sales revenues and net profit/loss (PLN m), 2004-2008
57. US Pharmacia revenues and net profit (PLN m), 2004-2009
58. The number of Rx-OTC status changes in Poland, 2008-2010
59. Sales per capita (€) on the Polish pharmaceutical market in comparison with selected developing countries, 2007-2009
60. Sales per capita (€) on the Polish pharmaceutical market in comparison with European countries with the highest sales, 2007-2009
61. Sales of OTC products as a percentage of sales of the pharmacy market in Poland, 2005-2009
62. Sales of dietary supplements as a percentage of sales of OTC products in Poland, 2005-2009
63. Reasons for switching dispensing categories of products cited by responding companies in Poland (number of responses), 2010
64. Benefits of switching dispensing categories of products in Poland (number of responses), 2010
65. Barriers in switching dispensing category of medicinal products in Poland, 2010
66. Assessment of switch costs in Poland (number of indications), 2010
67. Assessment of the time necessary for switch in Poland, 2010
68. Which type of dispensing category change is the most beneficial to company? (number of responses), 2010
69. Awareness of the Ketonal Lek brand after Rx-to-OTC switch in Poland, 1-12 months after change
70. Switch processes performed in the past by responding pharmaceutical companies in Poland (number of responses), 2010
71. Projected changes in dispensing categories of preparations in Poland (number of responses), 2010
72. Positive view of switch by pharmaceutical companies in their marketing strategies in Poland (number of responses), 2010
73. Pharmaceuticals most likely to make the switch from Rx to OTC in the next two years in Poland, July 2009
74. Location of pharmaceutical wholesalers’ warehouses in Poland, by voivodship, August 2010
75. Market shares of largest players on the pharmaceutical wholesale market in Poland, by sales to pharmacies, Q3 2010
76. Neuca group sales revenues (PLN m) and y-o-y change in Poland, 2003-H1 2010
77. Sales structure of Neuca in Poland, by subsidiaries, H1 2010
78. Neuca net profit (PLN m) and y-o-y change in Poland, 2003-H1 2010
79. Farmacol group sales revenues (PLN m) and y-o-y change in Poland, 2004-H1 2010
80. Structure of the Farmacol Group’s sales in Poland, 2009
81. Farmacol net profit (PLN m) and y-o-y change in Poland, 2004-H1 2010
82. PGF group sales revenues (PLN m) and y-o-y change, 2001-H1 2010
83. Sales structure of the PGF group, by division, 2009
84. PGF net profit (PLN m) and y-o-y change, 2001-H1 2010
85. OPDF shareholder structure in Poland, 2009
86. Hurtap sales revenues and net profit in Poland (PLN m), 2006-2009
87. Intra sales revenues and net profit in Poland (PLN m), 2006-2008
88. Medicare sales revenues and net profit in Poland (PLN m), 2006-2008
89. Lubfarm revenues and net profit in Poland (PLN m), 2006-2008
90. Preska revenues and net profit/loss in Poland (PLN m), 2005-2007
91. ACP Pharma wholesale revenues (PLN m) and y-o-y change in Poland, 2005-H1 2010
92. The structure of ACP Pharma’s sales in Poland, Q2 2010
93. Number of pharmacies and pharmacy outlets in Poland, 2001-May 2010
94. Average monthly revenues of pharmacies (PLN ‘000) and their dynamics in Poland, August 2009-August 2010
95. The number of pharmacies owned by pharmacy chains in Poland, 2009
96. Selected largest pharmacy chains in Poland, by number of outlets, September 2010
97. The number of franchise, own and partner pharmacies of the Dbam o Zdrowie chain in Poland, Q2 2010
98. Pharmacies belonging to Farmacol in Poland, by name, December 2009
99. ACP Pharma retail sales revenues in Poland (PLN m) and y-o-y change, 2005-H1 2010
100. Revenues and net profit/loss of BRL Center in Poland (PLN m), 2004-2008
101. Euro Apteki sales revenues and net profit/loss in Poland (PLN m), 2003-2008
102. Product categories that will sell best in general stores over the next two years in Poland, 2009
103. Shares of various retail formats in the grocery market in Poland, by value, 2009
104. Number of petrol stations owned by the major fuel concerns in Poland, H1 2010
105. Estimated number of kiosks in the chains of the largest press distributors in Poland, H1 2010
106. Selected largest cosmetics/drugstore chains in Poland (no. of stores), H1 2010
107. Most popular internet pharmacies in Poland, by numbers of real users, October 2009
108. Most popular internet pharmacies in Poland by numbers of hits, October 2009
109. Best-selling product categories in the internet channel over the next two years in Poland, 2009
110. Advertising spending of the largest advertisers in the pharmaceutical industry in Poland (PLN m), Q1-Q3 2009
111. Advertising spending of the largest advertisers in the OTC industry in Poland (PLN m), H1 2009 and H1 2010
112. The number of media used in advertising by pharmaceutical companies in Poland, H1 2010
113. Pharmaceutical companies’ spending on TV advertising in Poland (PLN m), Q1-Q3 2010
114. Spending on TV advertising by the largest advertisers in the pharmaceutical industry in Poland (PLN m), January-July 2009 and January-July 2010
115. Selected top brands of OTC products in terms of TV advertising in Poland, by amount spent (PLN m), September 2009-January 2010
116. Radio advertising spending of manufacturers of pharmaceutical products and medicines in comparison with other industries in Poland, 2009
117. Selected leading radio advertisers of drugs in Poland, by amount spent, 2009
118. Spending on outdoor advertising in the pharmaceutical sector in Poland (PLN ‘000) and spending change, 2006-H1 2010
119. The number of promotions of OTC products in promotional magazines in Poland, by format of retail outlet, 2008-2009
120. Number of OTC product promotions in promotional retail magazines in Poland, by product category, 2008 and 2009
121. Spending on TV advertising on Niquitin by GlaxoSmithKline in Poland (PLN m) and y-o-y change, 2005-Q1 2010
122. L’Oreal’s spending on the TV advertising of Vichy products in Poland (PLN m), selected weeks of 2010
123. The chart of performing variation of type II in the procedure of post-registration variations in the mutual recognition procedure in Poland, 2010
124. Assessment of the general health condition by Poles, 2008
125. Assessment of satisfaction with health in Poland, 1991-2009
126. Satisfaction with health as compared with other aspects of life in Poland, 2009
127. Assessment of Poles’ health in comparison with selected European countries, 2008
128. Actions taken by Poles’ to improve their health, 2008 vs. 2006
129. Frequency of exercises or sports activity practiced by Poles, 2009
130. Practicing sports or other type of exercises to maintain or improve fitness, July 2003 and July 2009
131. Poles’ attempts at losing weight/dieting on one’s own, 2009
132. Perceived weight compared with real weight in Poland, 2009
133. Poles’ most frequent disorders and diseases, 2008
134. The most frequent illnesses, disorders and types of pain of Polish women, 2010
135. Poles’ satisfaction with body shape and appearance, July 2003 and July 2009
136. Changes which Poles (women and men) would like to make to their appearance, 2009
137. Actions taken by Poles suffering from pain or ailments, 2009
138. The main reasons for not taking medicines by patients in Poland, 2009
139. The main reasons for not taking medicines by patients, Poland compared to the European average, 2009
140. Categories of OTC products most frequently used by Poles (% of responses), 2010
141. Factors influencing decision which OTC product to buy, Poland in comparison with the European average, 2009
142. Poles’ opinions on purchases of OTC medicines, 2006 and 2008
143. The key and most reliable sources of information on health used by Poles, 2008
144. Reliability of individual sources of information about the A/H1N1 flu in the opinion of Poles, 2009
145. Sources of information on the proper use of OTC medicines in Poland, 2009
146. Consulting the use of the OTC medicine with the doctor or pharmacist in Poland, 2010
147. Consulting the usage of the OTC medicine with the product information leaflet in Poland, 2010
148. Source of information on the proper usage of OTC medicines, Poland in comparison with the European average, 2009
149. Impact of the economic crisis on purchases and usage of OTC medicines in Poland, 2009
150. Impact of the economic crisis on purchases and usage of OTC drugs, Poland in comparison with the European average, 2009
151. Where did you buy medicines, personal care products, medical devices, etc. in 2009?
152. Percentage of persons using the internet in Poland, by age, 2009
153. The percentage of persons buying OTC drugs through the internet in Poland, by age, 2009
154. The percentage of persons buying OTC drugs through the internet in Poland, by education, 2009
155. The percentage of persons buying OTC drugs through the internet in Poland, by professional status, 2009
156. The percentage of persons buying OTC drugs through the internet in Poland, by income, 2009
157. The percentage of persons buying OTC drugs through the internet in Poland, by place of residence, 2009
158. Most popular medicines and dietary supplements sought in internet pharmacies in Poland, May 2010
159. Real change of GDP in Poland, 2000-2012
160. Unemployment rate in Poland (end of period), 2006-2012
161. Average gross monthly wages in Poland (PLN), 2000-2009
162. Yearly indexes for the prices of consumer goods and services in Poland, 2000-2012
163. Average monthly income and spending per capita in Polish households (PLN), 2000-2009
164. Population in Poland by place of residence, 2009
165. Percentage of urban population in Poland by region, 2009

LIST OF TABLES

1. Hypermarket chains in Poland by value of sales and number of outlets, 2008 and 2009
2. Largest supermarket chains in Poland by value of sales and number of outlets, 2008 and 2009
3. Discount chains in Poland by value of sales and number of outlets, 2008 and 2009
4. Largest chains of small grocery stores in Poland by value of sales and number of outlets, 2008 and 2009
5. Largest convenience store chains in Poland, by value of sales and number of stores, 2008 and 2009
6. Energy-boosting products which are the most frequently promoted in retailers’ magazines in Poland (number of promotions), 2009
7. Complementary products and dietary supplements most advertised in retailers’ magazines in Poland (number of promotions), 2009
8. Analgesics and cold remedies most advertised in retailers’ magazines in Poland (number of promotions), 2009
9. Most watched commercials of selected pharmaceutical products in Poland, GRP, number of spots and spending on advertising, selected weeks, 2010
10. Orders demanding the cessation of the advertising of medicinal products addressed to the public in Poland, 2010
11. Comparison of premises standards and staff qualification requirements applying to the sale of medicinal products by herbal medical stores, general stores/specialist medical supplies stores and pharmacy outlets in Poland, 2010
12. Comparison of staff qualification requirements dispensing medicinal products at herbal medical stores, general stores/specialist medical supplies stores and pharmaceutical outlets in Poland, 2010
13. The number and criteria of medicinal products approved for sale at pharmacy points, herbal medical outlets, general stores and specialist medical supplies stores in Poland, 2010
14. List of active substances approved for trade in general stores and specialist medical supplies stores in Poland, 2010
15. New chemicals forms approved for use in the production of dietary supplements in Poland, 2010
16. Reference values for vitamins and minerals for the labelling on dietary supplements in Poland, 2010 in comparison with the previous value
17. Documents required for type II variation in Poland, 2010
18. Charges for filing a type II variation application in Poland, 2010
19. Planned charges for filing an application for type II variation in Poland, 2010
20. Basic macroeconomic indexes of Poland, 2008-2009
21. The largest Polish urban agglomerations by number of inhabitants, 2009
LIST OF GRAPHS

LIST OF TABLES

Skip to top


Ask Your Question

OTC market in Poland 2010. Switch strategies and development forecasts for 2010-2012.
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: